Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
1 - 10 out of 139Page size: 10
Sort by: 1st author
  1. Published

    Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

    Abou-Alfa, G. K., Andersen, J. B., Chapman, W., Choti, M., Forbes, S. J., Gores, G. J., Hong, T. S., Harding, J. J., Vander Heiden, M. G., Javle, M., Kelley, R. K., Kwong, L. N., Lowery, M., Merrell, A., Miyabe, K., Rhim, A., Saha, S., Sia, D., Tanasanvimon, S., Venook, A. & 7 others, Valle, J. W., Walesky, C., Whetstine, J., Willenbring, H., Zhu, A. X., Mayer, D. & Stanger, B. Z., Dec 2016, In: Journal of Gastrointestinal Oncology. 7, 6, p. 819-827 9 p.

    Research output: Contribution to journal › Conference article › Research › peer-review

  2. Published

    MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism

    Akita, H., Marquardt, J. U., Durkin, M. E., Kitade, M., Seo, D., Conner, E. A., Andersen, Jesper Bøje, Factor, V. M. & Thorgeirsson, S. S., 4 Sep 2014, In: Cancer Research.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    Al-Abdulla, R., Lozano, E., Macias, R. I. R., Monte, M. J., Briz, O., O'Rourke, Colm, Serrano, M. A., Banales, J. M., Avila, M. A., Martinez-Chantar, M. L., Geier, A., Andersen, Jesper Bøje & Marin, J. J. G., 2019, In: British Journal of Pharmacology. 176, 6, p. 787-800

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Stromal yin-yang of myofibroblasts and endothelial cells in the progression of intrahepatic cholangiocarcinoma

    Andersen, Jesper Bøje, 2022, In: Hepatology. 76, 5, p. 1233-1236

    Research output: Contribution to journal › Editorial › Research

  5. Published

    Single cell profiling reveals window for immunotherapy in liver cancers

    Andersen, Jesper Bøje, 2018, In: Hepatobiliary surgery and nutrition. 7, 1, p. 48-51 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities

    Andersen, Jesper Bøje & Thorgeirsson, S. S., Apr 2013, In: Gastroenterology. 144, 4, p. 687-90 4 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  7. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?

    Andersen, Jesper Bøje & Hassel, B. A., Dec 2006, In: Cytokine & Growth Factor Reviews. 17, 6, p. 411-21 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  8. Progenitor-derived hepatocellular carcinoma model in the rat

    Andersen, Jesper Bøje, Loi, R., Perra, A., Factor, V. M., Ledda-Columbano, G. M., Columbano, A. & Thorgeirsson, S. S., Apr 2010, In: Hepatology. 51, 4, p. 1401-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Fibrolamellar Hepatocellular Carcinoma: A Rare But Distinct Type of Liver Cancer

    Andersen, Jesper Bøje, 24 Feb 2015, In: Gastroenterology.

    Research output: Contribution to journal › Editorial › Research › peer-review

  10. Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

    Andersen, Jesper Bøje, Mazan-Mamczarz, K., Zhan, M., Gorospe, M. & Hassel, B. A., 2009, In: RNA Biology. 6, 3, p. 305-15 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 93714085